1. Home
  2. CLST vs CUE Comparison

CLST vs CUE Comparison

Compare CLST & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLST
  • CUE
  • Stock Information
  • Founded
  • CLST 1922
  • CUE 2014
  • Country
  • CLST United States
  • CUE United States
  • Employees
  • CLST N/A
  • CUE N/A
  • Industry
  • CLST
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLST
  • CUE Health Care
  • Exchange
  • CLST Nasdaq
  • CUE Nasdaq
  • Market Cap
  • CLST 51.0M
  • CUE 58.9M
  • IPO Year
  • CLST N/A
  • CUE 2018
  • Fundamental
  • Price
  • CLST $11.74
  • CUE $0.78
  • Analyst Decision
  • CLST
  • CUE Strong Buy
  • Analyst Count
  • CLST 0
  • CUE 3
  • Target Price
  • CLST N/A
  • CUE $3.00
  • AVG Volume (30 Days)
  • CLST 6.2K
  • CUE 158.3K
  • Earning Date
  • CLST 04-24-2025
  • CUE 05-20-2025
  • Dividend Yield
  • CLST N/A
  • CUE N/A
  • EPS Growth
  • CLST N/A
  • CUE N/A
  • EPS
  • CLST 0.57
  • CUE N/A
  • Revenue
  • CLST $11,257,000.00
  • CUE $9,287,000.00
  • Revenue This Year
  • CLST N/A
  • CUE N/A
  • Revenue Next Year
  • CLST N/A
  • CUE $25.99
  • P/E Ratio
  • CLST $20.69
  • CUE N/A
  • Revenue Growth
  • CLST 192.24
  • CUE 69.16
  • 52 Week Low
  • CLST $10.67
  • CUE $0.45
  • 52 Week High
  • CLST $12.10
  • CUE $2.26
  • Technical
  • Relative Strength Index (RSI)
  • CLST 58.53
  • CUE 46.03
  • Support Level
  • CLST $11.52
  • CUE $0.71
  • Resistance Level
  • CLST $11.79
  • CUE $0.78
  • Average True Range (ATR)
  • CLST 0.14
  • CUE 0.06
  • MACD
  • CLST 0.05
  • CUE 0.01
  • Stochastic Oscillator
  • CLST 92.75
  • CUE 46.11

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: